TTrialPathMatch Me to Trials
← Back to trials
RecruitingVenous StenosisVenous Occlusion

WRAP North America

Eligible age

18+ yrs

Accepts

All genders

Locations

10 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this observational study is to investigate the safety and efficacy of the WRAPSODY CIE in a real-world North American population. Participants treated with the WRAPSODY CIE device in accordance with the device instructions for use will be followed in accordance with standard of care up to 3-years post-procedure.

Sponsor: Merit Medical Systems, Inc.

You may qualify if…

  • 1. Subject provides written informed consent for study participation.
  • 2. Subject is male or female, with an age ≥ 18 years at date of enrollment.
  • 3. Subject is willing to comply with site standard of care procedures and follow-up visit schedules over 36 months.
  • 4. Subject is undergoing chronic hemodialysis with the hemodialysis access the intervention will be performed upon.
  • 5. The dialysis access is considered mature and has been used to deliver hemodialysis treatments for at least one session.
  • 6. Subject has stenosis or occlusion within the dialysis outflow circuit and is treated with WRAPSODY CIE in accordance with device instructions for use.

You may not qualify if…

  • 1. Subject has a planned surgical revision of access site.
  • 2. Subject has a known or suspected infection of the hemodialysis access site, systemic infection and/or septicemia.
  • 3. Subject has an uncorrectable coagulation disorder.
  • 4. Known hypersensitivity to nickel or titanium.
  • 5. Subject's hemodialysis access is anticipated to be abandoned within 6 months.
  • 6. Subject is scheduled for kidney transplant or peritoneal dialysis within the next 6 months post-procedure.
  • 7. Full expansion of a PTA balloon cannot be achieved during predilatation.
  • 8. Device would be placed in the Superior Vena Cava

Where it's recruiting

Alabama

Dothan

Arizona

Phoenix

California

Riverside

Florida

Jacksonville · Sarasota

Kentucky

Lexington

Rhode Island

Providence

South Carolina

Charleston · Orangeburg · Spartanburg

Tennessee

Memphis

Texas

Fort Worth · Humble · San Antonio

Virginia

Virginia Beach

Source: ClinicalTrials.gov · NCT06807099 · last updated 2026-06-17